Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infliximab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02359903
What this trial is testing

Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Biocad 90
Not applicableStudy completedNCT02605642
What this trial is testing

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade

Who this might be right for
Rheumatoid DiseasesRheumatoid ArthritisAnkylosing Spondylitis+1 more
Pfizer 351
Post-approval studies (Phase 4)Study completedNCT05340764
What this trial is testing

Safety of Reduced Infliximab Infusion Time

Who this might be right for
Inflammatory Bowel Diseases
Washington University School of Medicine 96
Not applicableStudy completedNCT06381518
What this trial is testing

Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease

Who this might be right for
IBDInfliximabCrohn Disease+1 more
Zuyderland Medisch Centrum 38
Not applicableStudy completedNCT05796245
What this trial is testing

Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

Who this might be right for
Arthritis, RheumatoidColitis, UlcerativeCrohn Disease+1 more
Pfizer 2,207
Testing effectiveness (Phase 2)Looking for participantsNCT07657312
What this trial is testing

Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma

Who this might be right for
Cytokine Release SyndromeRecurrent Multiple MyelomaRefractory Multiple Myeloma
Naresh Bumma 35
Post-approval studies (Phase 4)Study completedNCT04982172
What this trial is testing

Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel Diseases

Who this might be right for
Inflammatory Bowel Diseases
Universitaire Ziekenhuizen KU Leuven 80
Testing effectiveness (Phase 2)WithdrawnNCT02126020
What this trial is testing

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolysis (Lyell) SyndromeMucous Membrane Pemphigoid
James Chodosh, MD, MPH
Early research (Phase 1)UnknownNCT00695682
What this trial is testing

Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)

Who this might be right for
Diabetic RetinopathyMacular Degeneration
Retina Research Foundation 4
Not applicableUnknownNCT04196920
What this trial is testing

Methotrexate-associated Anti-TNF Combination Therapy, the Neglected One !

Who this might be right for
Chronic Inflammatory Bowel Disease
University Hospital, Montpellier 200
Post-approval studies (Phase 4)Enrolling By InvitationNCT04646187
What this trial is testing

De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesCrohn DiseaseColitis, Ulcerative
University Medical Center Groningen 148
Large-scale testing (Phase 3)Study completedNCT00629772
What this trial is testing

Safety and Efficacy of Infliximab in Palmoplantar Psoriasis

Who this might be right for
Palmoplantar Psoriasis
Innovaderm Research Inc. 24
Post-approval studies (Phase 4)Study completedNCT00686595
What this trial is testing

Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 48
Post-approval studies (Phase 4)Study completedNCT00574470
What this trial is testing

Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD

Who this might be right for
Graft vs Host Disease
University of Iowa 3
Post-approval studies (Phase 4)Ended earlyNCT00752622
What this trial is testing

Treatment With Infliximab in a Medical Setting (Study P05587)

Who this might be right for
Crohn's Disease
Merck Sharp & Dohme LLC 100
Early research (Phase 1)Study completedNCT00228839
What this trial is testing

GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Emory University
Not applicableStudy completedNCT00955123
What this trial is testing

Effects of Prednisolone and Infliximab on the Regulation of Urea Synthesis in Active Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel Diseases
University of Aarhus 40
Testing effectiveness (Phase 2)Looking for participantsNCT05180994
What this trial is testing

Topical Infliximab in Eyes With Penetrating Keratoplasty

Who this might be right for
Glaucoma Following Surgery
Centre hospitalier de l'Université de Montréal (CHUM) 50
Not applicableStudy completedNCT01981473
What this trial is testing

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

Who this might be right for
Rheumatoid Arthritis
Pfizer 605
Testing effectiveness (Phase 2)Active Not RecruitingNCT04407247
What this trial is testing

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

Who this might be right for
ColitisLung Non-Small Cell CarcinomaMalignant Genitourinary System Neoplasm+2 more
M.D. Anderson Cancer Center 47
Next Page